Objectives. Because sudden death due to complete atrioventricular (AV) block or ventricular arrhythmias is the most dramatic event in myotonic dystrophy, we assessed the relation of cardiac disease to cytosine-thymine-guanine (CTG) triplet mutation in adults affected with myotonic dystrophy.
with the highest values in the group with fewer repeat expansions. The incidence of complete left bundle branch block was also significantly different among the groups (5% in El, 0% in Ez, 42% in E3 + E4, p = 0.01) and was directly correlated with the size of the expansion. A time-domain analysis of the signal-averaged ECG obtained in 12 patients in El, 4 in Ea, 5 in E 3 and 1 in E 4 showed that abnormal ventricular late potentials were directly correlated with CTG expansion (33% in E~, 75% in E2, 83% in E 3 + E4, p = 0.05). Moreover, the incidence of ventricular couplets or triplets showed a positive correlation with size of CTG expansion (0 in El, 0 in E2, 29% in E 3 + E4, chi square 0.02).
Conclusions. Our findings suggest that the involvement of specialized cardiac tissue, accounting for severe AV and intraventricular conduction defects, is related to CTG repeat length. In addition, the presence of abnormal late potentials directly correlates to CTG expansion. Abnormal late potentials, caused by slowed and fragmented conduction through damaged areas of myocardium, represent a substrate for malignant reentrant ventricular arrhythmias. In the future, therefore, molecular analysis of DNA should identify patients with cardiac disease at high risk for development of AV block or lethal ventricular arrhythmias.
(J Am Coll Cardiol 1995; 25:239-45) Myotonic dystrophy, the most common muscular dystrophy in adults (1) , has multiple systemic effects, including neuromuscular manifestations, cataracts, mental retardation and cardiac involvement. Overt primary myocardial disease in myotonic dystrophy is rare, but conduction disturbances are frequent (2) (3) (4) (5) . Moreover, patients with myotonic dystrophy are reported to have a higher incidence of sudden death than the general population, and the observed deaths occur either from complete atrioventric-ular (AV) block or ventricular arrhythmias (4, (6) (7) (8) . Myotonic dystrophy is an autosomal dominant disorder with incomplete penetrance and variable expressivity. The myotonic dystrophy mutation was recently identified as an unstable trinucleotide cytosine-thymine-guanine (CTG) repeat, resulting in a variablelength polymorphism, which maps to chromosome 19q 13.3 and is located within a 10-kilobase (kb) deoxyribonucleic acid (DNA) sequence (9) (10) (11) . The trinucleotide repeat, which is present 5 to 30 times in the normal population, was found to be amplified up to 2,000 times in patients with myotonic dystrophy (12) (13) (14) . In a previous study (15) , the age at onset and the severity of skeletal muscular disease were reported to be correlated with CTG trinucleotide amplification. Because sudden death is the most dramatic event in myotonic dystrophy, the purpose of this study was to assess the relation between the severity of cardiac disease and CTG trinucleotide repeat length.
Methods
Patients. We studied 42 patients (30 men, 12 women; mean [_+SD] age 39 _+ 4 years, range 18 to 82) from 24 myotonic dystrophy pedigrees. Myotonic dystrophy was diagnosed in our Neuromuscular Center on the basis of neurologic examination, electromyography, muscle biopsy and DNA analysis (16) . This diagnosis was also based on a positive family history compatible with an autosomal dominant inheritance. Clinical variables evaluated included neuromuscular manifestations, ocular abnormalities and cardiac disease. The severity of skeletal muscle involvement was scored as follows: mild = myotonia only by either clinical examination or electrophysiologic study; moderate = muscle atrophy in the distal forearm or leg muscles; severe = marked limb hypotonia, severe muscle atrophy or severe weakness resulting from involvement of facial, neck and distal limb muscles. Clinical evaluation and grading were performed throughout by the same observer.
Cardiac evaluation. Cardiac evaluation in all 42 patients was based on history, physical examination, chest radiography, electrocardiography and echocardiography. In addition, signalaveraging electrocardiography was performed in 22 patients, and 24-h Holter monitoring was recorded in 32. Intracardiac electrophysiologic studies were performed in only the three symptomatic patients. These invasive methods would have provided additional data about the abnormalities of impulse formation and conduction in the other patients, but for the purpose of the present study, we focused on the scalar electrocardiogram (ECG), Holter monitoring and the signalaveraged ECG.
Signal-averaged ECG. The signal-averaged ECG was recorded in the absence of drug therapy using a commercially available system (Marquette MAC 15) during sinus rhythm (standard bipolar orthogonal leads x, y and z); 250 beats were averaged to obtain a noise level of <0.6/zV. The signals were amplified, digitized, averaged and filtered with a bidirectional filter at frequencies of 40 to 250 Hz. Late potentials were considered to be present in patients with normal ECG findings or with hemiblock if two or three standard variables were abnormal: filtered QRS complex duration ->117 ms, filtered complex duration after the voltage decrease to <40 p~V ->34 ms and root-mean-square voltage during the last 40 ms of the filtered QRS complex -<24 p~V (normal values in our laboratory _+1 SD). In patients with complete right or left bundle branch block, these variables were considered abnormal as follows: filtered QRS duration ->145 ms; filtered complex duration ->45 ms after the voltage decrease to <40 p~V and root-mean-square voltage -<17 p~V during the last 40 ms of the filtered QRS complex (17) . Twenty-four hour Holter monitorings were obtained using modified leads V1 and V 5 and a portable ICR 24-h tape recorder. Tapes were analyzed by a rapid scanner with a digital circuit for arrhythmia detection and date reduction (Pathfinder model 3). During 24-h Holter monitoring, the patients followed their normal daily routine and kept a diary of symptoms and activity levels. Ventricular arrhythmias were classified according to the Lown scale.
A phased-array ultrasound system (Sonos 1000 77030 A) with duplex 2.5-and 3.5-MHz transducers and a 2.0-MHz nonimaging transducer for imaging, spectral Doppler and color flow mapping was used. Standard parasternal, apical and subcostal views were stored on Panasonic AG 6200 videotapes that allowed frame-by-frame and real-time playback for detailed evaluation of structures and function. Two-dimensional studies were evaluated by two independent observers. Left ventricular volumes were calculated using an ellipsoid arealength model derived from left ventricular imaging in the apical four-chamber view. Ejection fraction was calculated as follows: end-diastolic volume minus end-systolic volume divided by end-diastolic volume (18) . End-diastolic and endsystolic right ventricular volumes were calculated by an arealength method derived from orthogonal planes (apical fourchamber and short-axis subcostal views) (19) .
After two-dimensional examination, mitral flow from the cardiac apex was evaluated by Doppler ultrasound; the sample volume was placed in the left ventricular inflow tract at the level of the mitral leaflet tips (20, 21) . Variables of diastolic function included 1) early (E) and atrial (A) filling velocity peaks; 2) ratio of early to atrial peaks (E/A); 3) time-velocity integral of the atrial and early filling velocity curves; and 4) ratio of time-velocity integral of early filling velocity curve to time-velocity integral of atrial filling velocity curve.
The following criteria for the presence of mitral valve prolapse on echocardiography were applied: bowing of mitral leaflet(s) extended >5 mm above the plane of the mitral ring in the parasternal long-axis, four-chamber view; left atrial coaptation point; and moderate or severe Doppler mitral regurgitation with any degree of leaflet bowing (22, 23) .
DNA analysis. Twenty milliliters of venous blood was collected from each of the 42 patients. The range of CTG amplification in DNA was evaluated in a control group of 100 adult donors from the National Blood Transfusion Centre of the Italian Red Cross, Rome. Genomic DNA (10 /~g) was digested with EcoRI or BamHI restriction enzymes, according to the manufacturer's instructions (Bio-Rad), electrophoresed on 0.8% agarose gels and transferred onto nylon membranes (Hybond N, Amerrsham). Southern blots were probed with the 1.4-kb Barn-HI fragment on the MDY 1 cosmid containing the variable CTG repeat (12) . Hybridime (HT Bioteehnology) was included at a concentration of 0.25 mg/ml in both the prehybridization and hybridization solutions. Blots were washed in 1 × sodium chloride/sodium citrate (SSC) and 0.1% sodium dodecyl sulfate (SDS) at 65°C and then exposed to AGFA XAR film for 1 to 4 days. CTG polymorphism was detected by the polymerase chain reaction technique using 101 and 102 flanking synthetic oligonucleotides, according to Brook et al. (24) . The number of CTG trinucleotide repeats was established for each patient by length variation on Southern blotting (EcoRI and/or BamHI) and polymerase chain reaction.
CTG trinucleotide amplification. The CTG trinucleotide repeat length was classified using the following scale: E 1 = expansion of 0 to 1.5 kb (corresponding to 0 to 500 CTG repeats), 18 patients; E2 = expansion of 1.5 to 3.0 kb (up to 1,000 repeats), 12 patients; E 3 = expansion of 3.0 to 4.5 kb (up to 1,500 repeats), 10 patients; E 4 = expansion >4.5 kb (>1,500 repeats), 2 patients. Because the number of patients in the E 4 category was very small, the entire group was subdivided into three subgroups (El, E2, E3 + E4).
Statistical analysis. Continuous variables were analyzed by a general linear model procedure for unbalanced data. The data were stratified according to age and entity of CTG expansion. Mean values were compared for significant differences by the Tukey all-pairwise comparisons. Categoric variables were analyzed by means of contingency tables according to the entity of CTG expansion. Different risk rates were tested by the Mantel-Haenszel chi-square method. Significant variables were further analyzed with a test for logistic trend to take the increasing entity of CTG expansion into account to control for age confounding. The age of patients was forced in the logistic model. Linear regression analysis was used to assess the correlation between the age at disease onset and CTG expansion. The linear correlation between skeletal muscle involvement and CTG expansion was tested using the Spearman rho test. The difference in CTG expansion among the four subgroups of progressive skeletal involvement was tested for significance using the general linear model analysis of variance Fisher least significant difference test.
Results
Age at onset and skeletal muscle involvement. The age of our patients at disease onset ranged from 10 to 80 years (mean [_+SD] 27.5 _+ 13.4). We observed an inverse correlation between age at disease onset and CTG expansion (Fig. 1 ), (r = 0.39, p <0.0001). No skeletal muscle involvement was found in 7 patients (17%); muscular involvement was mild in 8 (19%), moderate in 7 (17%) and severe in 20 (47%). A direct correlation between expansion and skeletal muscle involvement is shown in Figure 2 ; patients with severe involvement had a significant increase in the number of CTG triplets (mean 
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Ea + E4 ctg expansion Figure 2 . Distribution of skeletal muscle severity in the three subgroups of patients, grouped according to extent of CTG expansion: El = 0 to 500 CTG repeats; E 2 = up to ],000 repeats; E 3 = up to 1,500 repeats; E 4 = >1,500 repeats; ctg = cytosine-thymine-guanine.
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Cardiac involvement.
Only three patients were clinically symptomatic, with near-syncope manifestations. Most of the patients were asymptomatic, and 18 (43%) had normal findings on ECG tracings. Table 1 reports the percent of ECG abnormalities observed. However, more than one abnormality was present in one subject, and a multilevel conduction system impairment was evident in eight: four had a first-degree AV block plus left anterior fascicular block; two had a first-degree AV block plus complete left bundle block; one had a firstdegree AV block plus right bundle block and complete left bundle block; and one had a first-degree AV block plus right bundle block and left fascicular block. Two symptomatic patients had a first-degree AV block with anterior fascicular block and a right bundle branch block with anterior fascicular block, respectively. Electrophysiologic study documented the presence of an infrahisian block in both patients, with HV intervals of 80 and 95 ms, respectively, and pacemakers were implanted.
The third symptomatic patient had a sinus bradycardia and a first-degree AV block. However, electrophysiologic study did not detect sinus node dysfunction or infrahisian block (AH 10 × unit. Data presented are number (%) of patients. E~ = expansion of 0 to 1.5 kb (corresponding to 0 to 500 CTG repeats); E 2 -expansion of 1.5 to 3.0 kb (up to 1,000 repeats); E3 = expansion of 3.0 to 4.5 kb (up to t,500 repeats); E4 = expansion >4.5 kb (>1,500 repeats); other abbreviations as in Table 1. interval 190 ms, HV interval 60 ms). The three symptomatic patients were followed up in our outpatient department. After pacemaker implantation, no further attacks appeared in one patient; therefore, we believe that the near syncope in this patient should be attributed to paroxysmal complete AV block. In contrast, the other two patients, one with and one without a pacemaker, continued to have near-syncopal episodes. In these patients a vasovagal vasodepressive pathogenesis or ventricular tachyarrhythmia was probably the underlying mechanism.
Relation between ECG and CTG expansion. The incidence of the single ECG abnormality in the three subgroups is reported in Table 2 according to the size of the CTG expansion. The incidence of normal ECG results was significantly different in the three subgroups, with highest values in the less expanded classes. The age-unconfounded odds ratio was 0.39. The incidence of complete left bundle branch block was directly correlated with CTG trinucleotide repeat length. The age-unconfounded odds ratio was 10.
Relation between presence of abnormal ventricular late potentials and CTG expansion. The presence of abnormal ventricular late potentials was investigated in 22 patients. Echocardiographie data. Echocardiograpfiic data for our patients with myotonic dystrophy are summarized in Table 3 . We calculated right and left ventricular volumes as well as ejection fraction for both ventricles by two-dimensional echo- Table 3 . No significant differences between groups were observed for E/A or IE/IA. However, three patients had abnormal ratios. We defined an abnormal E/A (<1) ratio and an abnormal IE/IA (<1.5) ratio as less than the mean value -2 SD in control subjects. In two, abnormal ratios were associated with left ventricular hypertrophy and systemic arterial hypertension, and in one other with regional wall motion abnormalities. On the basis of strict criteria to confirm the abnormality of mitral leaflet structure and function, a mitral prolapse was diagnosed in seven patients (17%). Abbreviations as in Tables 2 and 3 .
01). We used ratio of early (E) to atrial (A) filling velocity peaks and ratio of time-velocity integral of early velocity curve (IE) to atrial curve (IA) as indexes of diastolic function. Comparisons of such indexes between the patients and the control subjects are shown in
Myocardial function and CTG expansion. No significant difference existed among the three subgroups of patients with myotonic dystrophy with regard to left ventricular end-diastolic volumes and ejection fraction, right ventricular data or left ventricular diastolic function (Table 4) .
Arrhythmias and CTG expansion. Both bradyarrhythmias and tachyarrhythmias were evaluated. Table 5 shows the various arrhythmias that were detected in the patients with myotonic dystrophy along with the size of the CTG expansion. It appears that the most serious ventricular arrhythmias (couplets or triplets) occurred in the E 3 + E 4 subgroup.
Discussion
Previous studies. Myotonic dystrophy is an autosomal neuromuscular disorder characterized by extremely variable phenotypic expression and age of onset. Cardiac involvement is an integral part of myotonic dystrophy, targeting almost selectively the conduction system and, less specifically, the myocardium. Sudden death is the most grave cardiac threat and has been related to conduction block or malignant ventricular arrhythmias. The myotonic dystrophy gene was recently iso- Table 2. lated, and the molecular defect characterizing the myotonic dystrophy mutation was identified as an unstable DNA sequence (CTG repeat) at the T-untranslated region of a serine-threonine kinase gene located on 19q (12) encoding for a protein that was designated as myotonin.
The myotonin amino acid sequence is similar to a protein kinase that should act as second cell messenger (12, 24) . However, the effect of the repeat on gene transcription is still controversial, and it is not clear whether the mutation is a loss (25) or a gain in protein production function (26) . In any case, this recognized mechanism of "dynamic mutation" (27) (28) (29) (30) (31) (32) (33) (34) has provided a molecular explanation for the unusual genetic features observed in families with myotonic dystrophy, such as anticipation (30) (31) (32) , clinical variability (34) and incomplete penetrance (29) . Anticipation corresponds to a more severe expression and an earlier onset of the disease through generations as a result of the increase in the number of CTG repeats with subsequent generations through the affected pedigrees.
The opposite phenomenon, "reverse mutation" (28), is a meiotic regression in the size of the triplet expansion, which would bring the number of CTG repeats within the normal range and might account for incomplete penetrance; however, it seems to be a rare event.
Present study, In the current investigation we found a direct relation among degree of skeletal muscle involvement, earlier age at disease onset and expansion of the unstable sequence, in agreement with a previous report by Novelli et al. (15) . Moreover, by relating the myotonic dystrophy genotype to cardiac involvement, we observed a direct relation among specialized tissue disease, ventricular arrhythmias and CTG expansion.
Correlation between ECG data and CTG expansion. Overt clinical symptoms, such as syncope or near syncope, were rare in our patient series, but ECG findings, consisting of conduction defects, were abnormal in 57% of the patients. A significant inverse difference in the incidence of normal ECG findings was found among the three subgroups classified on the basis of CTG expansion. By contrast, a significant, direct correlation between complete left bundle branch block and CI'G expansion was evident.
Correlation between ventricular arrhythmias and CTG expansion. Sudden death has also been reported in patients with well functioning pacemakers, so ventricular arrhythmias seem to play an important role in the genesis of sudden death (6) (7) (8) . In our patients, malignant ventricular premature beats (ventricular couplets or triplets) were observed on 24-h Holter monitoring, and the incidence of these arrhythmias showed a positive, significant trend with the size of CTG expansion. Because signal-averaged electrocardiography can identify patients at high risk for lethal ventricular arrhythmias and sudden death (35, 36) , presumably by identifying the electrical manifestations of the anatomic substrates of these arrhythmias (37-38), we evaluated a smaller group of the study patients by this method. Milner et al. (39) previously showed that the prevalence of late potentials on signal-averaged electrocardiography in patients with myotonic dystrophy approached that seen in cardiac patients with inducible ventricular tachycardia.
A time-domain analysis of the signal-averaged ECG in our patients with myotonic dystrophy showed a significantly higher prevalence of abnormal delayed electrical activity in subjects with the most expanded CTG repeats. It is possible that focal areas of necrosis in the myocardium, and particularly in the primary conduction tissues, might be the site of the delayed electrical conduction detected in our series.
Ventricular myocardial function. Controversy exists regard-
ing the prevalence of preclinical left ventricular dysfunction in patients with myotonic dystrophy (40-45) who have no symptoms of heart failure, but overt signs of heart failure are rarely reported (5,46). In the current study, only a mild, statistically significant dilation was observed, in agreement with previously described structural abnormalities of the right ventricle (5). The aforementioned right ventricle dimensional and structural abnormalities could constitute the anatomic substrate for late potentials and arrhythmias. Indeed, no significant difference in left and right ventricular findings emerged in the three patient subgroups, classified on the basis of CTG expansion. In the current study, in only one patient could diastolic dysfunction be related to a myocardial dystrophic disease because the increase in peak atrial velocity was associated with wall motion abnormalities.
Conclusions. Our present study agrees with previous reports of a high incidence of conduction system defects and ventricular arrhythmias in patients with myotonic dystrophy. The ECG-molecular correlation that we observed could provide some information regarding the morbidity and prognosis in these patients. A predictive diagnosis obviously cannot be made in isolated cases solely on the basis of repeat length because there is a clear and significant overlap between the expansion sizes seen in the different phenotypic groups. Somatic mosaicism (i.e., the coexistence in the same subject of cell lines with different numbers of CTG repeats) constitutes a limiting factor; DNA is routinely obtained from lymphocytes and therefore may differ (in terms of CTG repeats) from the DNA of the specialized conduction system tissue.
Anvret et al. (67) compared DNA from blood and muscle samples from the same subject; the length of the repeat unit demonstrated somatic heterogeneity and was much greater in all the muscle samples. Therefore, to obtain a more precise correlation, it would be necessary to study DNA isolated from the cardiac muscle of patients with myotonic dystrophy. Although this may be possible in isolated patients undergoing electrophysiologic studies, ethical considerations would otherwise clearly preclude such an approach. Moreover, future studies should include messenger ribonucleic acid and myotonic dystrophy kinase from cardiac biopsy samples and attempt to detect the entity of kinase expression in this tissue compared with that in skeletal muscle. The underlying mechanism of myotonic dystrophy in the heart might thus be clarified.
